INGNQ Introgen Therapeutics Inc featured news, full reports, and detailed charts
Introgen Therapeutics Inc (INGNQ/INGNQ.PK) Wrap Up:
Introgen Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of targeted molecular therapies for the treatment of cancer and other diseases. The company is developing product candidates to treat a range of cancers using tumor suppressors, cytokines, and other targeted molecular therapies. Its lead product candidate include ADVEXIN therapy, which combines the p53 tumor suppressor with a non-replicating, non-integrating, and adenoviral delivery system. ADVEXIN therapy is in Phase III clinical trials in patients with advanced recurrent squamous cell carcinoma of the head and neck. The company’s product candidates also include INGN 241, a...www.introgen.com
80 Employees
Founded in 1993
Introgen Therapeutics Inc (INGNQ:OTC)
INGNQ Top Compensated Officers
Mr. J. David Enloe Jr.
Chief Executive Officer and President
Age: 45
Total Annual Compensation: $257.9K
Mr. James W. Albrecht Jr.
Chief Financial Officer, Principal Accounting...
Age: 54
Total Annual Compensation: $252.3K
Executives, Board Directors
Compensation as of Fiscal Year 2007.
Key developments for Introgen Therapeutics Inc (INGNQ)
Introgen Therapeutics Inc. announced delayed annual 10-K filing
03/16/2009
On 03/16/2009, Introgen Therapeutics Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
David G. Nance Resigns from the Board of Directors of Introgen Therapeutics and Introgen Technical Services
03/11/2009
Introgen Therapeutics Inc. announced that David G. Nance has resigned from the company's board of directors, effective immediately. Mr. Nance, who had served as Introgen's chairman, also resigned from the boards of Introgen Technical Services Inc., and the company's consolidated subsidiaries, with the exception of Gendux AB. Mr. Nance will remain a director for Gendux, Introgen's wholly-owned subsidiary based in Sweden, until further notice.
Introgen Therapeutics Files Form 15
03/11/2009
Introgen Therapeutics Inc. has announced that it has filed a Form 15 with the Securities and Exchange Commission for the purpose of deregistering its securities under the Securities Exchange Act of 1934. The par value of the common stock was $0.001 per share.
INGNQ Competitors
| Company | Last | Change | |
| No competitor information is available for INGNQ. | |||
| Market data is delayed at least 20 minutes. | |||
Industry Analysis
| Valuation | INGNQ | Industry Range |
| No financial data is available for INGNQ. | ||
|
INGNQ transactions
| Type Date |
Target | |
| No transactions in the last 6 months. | ||
More Recent News About Introgen Therapeutics Inc
More news for INGNQ
INTROGEN THERAPEUTICS INC Files SEC form 8-K, Change in Directors or Principal Officers
Show all filings for INTROGEN THERAPEUTICS INC | Request a Trial to NEW EDGAR Online Pro Form 8-K for INTROGEN THERAPEUTICS INC 13-Jan-2009Change in Directors or Principal Officers Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service - Copyright/IP Policy - Send Feedback SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational...Click here to read the whole Article (external link)
INTROGEN THERAPEUTICS INC Files SEC form 8-K, Regulation FD Disclosure
Show all filings for INTROGEN THERAPEUTICS INC | Request a Trial to NEW EDGAR Online Pro Form 8-K for INTROGEN THERAPEUTICS INC 22-Dec-2008Regulation FD Disclosure Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service - Copyright/IP Policy - Send Feedback SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, n...Click here to read the whole Article (external link)
INTROGEN THERAPEUTICS INC Financials
Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service - Copyright/IP Policy - Send Feedback Quotes delayed, except where indicated otherwise.Delay times are 15 mins for NASDAQ, 20 mins for NYSE and Amex. See also delay times for other exchanges.Fundamental company data provided by Capital IQ. Quotes and other information supplied by independent providers identified on the Yahoo! Finance partner page. Quotes are updated automatically, but will be turned off after 25 minutes of inactivity. Quotes are delayed at least 15 minutes. Real-...Click here to read the whole Article (external link)
INTROGEN THERAPEUTICS INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or S
Show all filings for INTROGEN THERAPEUTICS INC | Request a Trial to NEW EDGAR Online Pro Form 8-K for INTROGEN THERAPEUTICS INC 5-Dec-2008Notice of Delisting or Failure to Satisfy a Continued Listing Rule or S Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service - Copyright/IP Policy - Send Feedback SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information prov...Click here to read the whole Article (external link)
Biotech Mailbag: NeurogesX Patchy at Best
Stock quotes in this article: NGSX , DCTH , AMGN , ...Click here to read the whole Article (external link)
INTROGEN THERAPEUTICS INC Financials
Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service - Copyright/IP Policy - Send Feedback Quotes delayed, except where indicated otherwise.Delay times are 15 mins for NASDAQ, 20 mins for NYSE and Amex. See also delay times for other exchanges.Fundamental company data provided by Capital IQ. Quotes and other information supplied by independent providers identified on the Yahoo! Finance partner page. Quotes are updated automatically, but will be turned off after 25 minutes of inactivity. Quotes are delayed at least 15 minutes. Real-...Click here to read the whole Article (external link)
INTROGEN THERAPEUTICS INC Financials
Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service - Copyright/IP Policy - Send Feedback Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). International historical chart data and daily updates provided by Morningstar, Inc. Fundamental company data provided by Capital IQ. Quotes and other information supplied by independent providers identified on the Yahoo! Finance partner page. Quotes are updated automatically, but will be turned off after 25 minutes of inactivity. Quotes are delayed at least 15 minutes. R...Click here to read the whole Article (external link)
Would you like to leave a comment about Introgen Therapeutics Inc INGNQ/INGNQ.PK
Find out what social network information about Introgen Therapeutics Inc are available on RealpenniesWorst 5 - Click here to find out what stocks have been voted down by our visitors and users
Besides Introgen Therapeutics Inc there is more great information available at Realpennies.com